CODEX DNA INC (DNAY) Stock Price & Overview
NASDAQ:DNAY • US1920031010
Current stock price
The current stock price of DNAY is 1.3 USD. Today DNAY is up by 8.33%. In the past month the price decreased by -5.8%. In the past year, price decreased by -86.13%.
DNAY Key Statistics
- Market Cap
- 38.378M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.80
- Dividend Yield
- N/A
DNAY Stock Performance
DNAY Stock Chart
DNAY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to DNAY. When comparing the yearly performance of all stocks, DNAY is a bad performer in the overall market: 94.18% of all stocks are doing better.
DNAY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to DNAY. DNAY may be in some trouble as it scores bad on both profitability and health.
DNAY Earnings
DNAY Forecast & Estimates
9 analysts have analysed DNAY and the average price target is 6.63 USD. This implies a price increase of 410% is expected in the next year compared to the current price of 1.3.
For the next year, analysts expect an EPS growth of -6.4% and a revenue growth 106.09% for DNAY
DNAY Groups
Sector & Classification
DNAY Financial Highlights
Over the last trailing twelve months DNAY reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -63.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.37 |
DNAY Ownership
DNAY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.13 | 176.226B | ||
| DHR | DANAHER CORP | 22.3 | 133.897B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 124.29 | 40.886B | ||
| A | AGILENT TECHNOLOGIES INC | 16.63 | 31.453B | ||
| WAT | WATERS CORP | 20.58 | 29.331B | ||
| IQV | IQVIA HOLDINGS INC | 12.96 | 27.878B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.68 | 24.487B | ||
| ILMN | ILLUMINA INC | 23.76 | 19.01B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.26 | 17.085B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.96 | 12.842B | ||
| RVTY | REVVITY INC | 15.59 | 9.608B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.395B | ||
| TECH | BIO-TECHNE CORP | 23.14 | 8.054B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DNAY
Company Profile
Codex DNA, Inc. engages in research and development of genomic tools for biomedical and industrial applications. The company is headquartered in San Diego, California and currently employs 212 full-time employees. The company went IPO on 2021-06-18. Its synthetic biology solution addresses bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. The firm's products include BioXp systems, including BioXp 3250 system, BioXp kits for generating a range of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. The company has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. The company has placed approximately 200 BioXp systems globally.
Company Info
IPO: 2021-06-18
CODEX DNA INC
9535 Waples Street, Suite 100
San Diego CALIFORNIA US
CEO: Todd R. Nelson
Employees: 212
Phone: 18582284115.0
CODEX DNA INC / DNAY FAQ
What does CODEX DNA INC do?
Codex DNA, Inc. engages in research and development of genomic tools for biomedical and industrial applications. The company is headquartered in San Diego, California and currently employs 212 full-time employees. The company went IPO on 2021-06-18. Its synthetic biology solution addresses bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. The firm's products include BioXp systems, including BioXp 3250 system, BioXp kits for generating a range of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. The company has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. The company has placed approximately 200 BioXp systems globally.
What is the stock price of CODEX DNA INC today?
The current stock price of DNAY is 1.3 USD. The price increased by 8.33% in the last trading session.
What is the dividend status of CODEX DNA INC?
DNAY does not pay a dividend.
How is the ChartMill rating for CODEX DNA INC?
DNAY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting DNAY stock to perform?
9 analysts have analysed DNAY and the average price target is 6.63 USD. This implies a price increase of 410% is expected in the next year compared to the current price of 1.3.
What is the expected growth for DNAY stock?
The Revenue of CODEX DNA INC (DNAY) is expected to grow by 106.09% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for CODEX DNA INC?
CODEX DNA INC (DNAY) currently has 212 employees.